Pre-eclampsia Screening & Prevention in Al Ain

Pre-eclampsia screening in Al Ain is performed during the first trimester (11–14 weeks) at Mediclinic Al Jowhara Hospital. Using the Fetal Medicine Foundation (FMF) triple test algorithm—combining maternal history, blood pressure, uterine artery Doppler, and PLGF biomarkers—we identify high-risk patients to initiate early preventative therapy.

Who This Page is For

Customized clinical pathways and insights to support our patients and referring medical partners.

Pregnant Patient

All pregnant patients in their first trimester (11 to 14 weeks) seeking to assess and reduce their risk of pre-eclampsia.

Referring Doctor

Obstetricians looking to implement standardized, early risk calculation and preventative aspirin therapy.

Abnormal Screening

Mothers with chronic hypertension, diabetes, or prior history of pre-eclampsia.

Second Opinion

Patients wanting a detailed discussion on blood pressure monitoring and preventative medication safety.

When to see MFM

Screening must be performed between 11 weeks and 13 weeks 6 days of pregnancy.
Mothers with risk factors: first pregnancy, chronic hypertension, pre-pregnancy diabetes, or kidney disease.
History of pre-eclampsia, fetal growth restriction, or stillbirth in a prior pregnancy.
Pregnancies achieved through IVF.

What we do

Precise measurement of blood pressure in both arms to calculate Mean Arterial Pressure (MAP).
Uterine artery Doppler ultrasound to measure blood flow resistance in the maternal vessels.
Blood test to measure Placental Growth Factor (PLGF) biomarker levels.
FMF software risk calculation to identify high-risk patients (risk threshold 1 in 100).

What happens during the visit

1

An integrated clinical assessment including history, blood pressure, and ultrasound.

2

Maternal blood draw for biomarker analysis.

3

Generation of a combined risk report.

4

Immediate prescription of low-dose aspirin (150 mg nightly) before 14 weeks if identified as high-risk.

When urgent referral is needed

  • Severe, persistent headache or visual changes (flashing lights, blurriness).
  • Sudden, rapid swelling of the face, hands, or feet.
  • Severe pain in the upper abdomen (under the ribs).

Where the service is available

Available at Mediclinic Al Jowhara Hospital in Al Ain. Certain complex procedures are referred to our Abu Dhabi hub, with local pre-op and post-op care in Al Ain.

Why Fetus.ae / Mediclinic MFM

Strict adherence to the Fetal Medicine Foundation (FMF) international screening protocols.
Certified specialists accredited in first-trimester uterine artery Doppler measurements.
Centralized accredited pathology lab for precise and fast PLGF biomarker processing.
Effective prevention protocol, proven to reduce early-onset pre-eclampsia by up to 80%.

Mediclinic Al Jowhara Hospital

Appointments & Inquiries

800 2000

Clinical Working Hours

Clinic times vary by location and consultant. Please confirm when booking via 800 2000.

Specialists Available

Explore each doctor’s qualifications, clinical interests and verified practice location.

Dr. Ali Al-Ibrahim

Dr. Ali Al-Ibrahim

Head of Unit · Consultant Maternal–Fetal Medicine

Toronto fellowship training and more than 25 years of experience, bringing together fetal diagnosis, maternal medicine and coordinated care.

View Full Profile
Dr. Soha Tohamy Said

Dr. Soha Tohamy Said

Consultant Maternal–Fetal Medicine & Obstetrics and Gynecology

More than 28 years of clinical and leadership experience, with particular interests in maternal health and prevention of preterm birth.

View Full Profile
Dr. Najwa Ibrahim

Dr. Najwa Ibrahim

Consultant Maternal–Fetal Medicine

Care for complex pregnancies, with interests in advanced ultrasound, prenatal screening, fetal growth and placental health.

View Full Profile
Dr. Howaida Khair

Dr. Howaida Khair

Consultant Obstetrics and Gynecology

A seasoned obstetrician and gynecologist with a special interest in fetal medicine, prenatal ultrasound and counselling.

View Full Profile

Frequently Asked Questions

Clinical answers directly from our specialists to help prepare you for your appointment.

Pre-eclampsia is a pregnancy complication characterized by high blood pressure and signs of damage to organ systems, most often the kidneys, developing after 20 weeks.

Early screening before 14 weeks allows us to identify high-risk patients and start preventative aspirin therapy, which drastically reduces the risk.

It combines maternal history, measurement of blood pressure in both arms, uterine artery blood flow Doppler, and a blood test for PLGF.

Yes, low-dose aspirin (150 mg nightly) is highly safe for the baby and mother when started before 14 weeks under medical supervision.

Low-dose aspirin can reduce preterm pre-eclampsia risk in selected pregnancies when prescribed appropriately. It does not eliminate risk; your clinician advises whether it is suitable and plans surveillance.

A low-risk result is highly reassuring, meaning you are unlikely to develop early-onset pre-eclampsia, though routine blood pressure checks will continue.

Getting Here & Access

In Al Ain, we are based at Mediclinic Al Jowhara Hospital, a short drive from Al Jimi, Al Towiyya, Al Muwaiji, Al Mutaredh, Hili and Al Sarooj, with convenient parking. Al Ain families receive their scans, diagnostics and routine follow-up locally; the small number of highly specialised in-utero procedures are performed at our Abu Dhabi hub (about 90 minutes via the E22/Abu Dhabi–Al Ain Road) with pre-operative and post-operative care kept close to home in Al Ain.

Insurance & Coverage

The Al Ain unit works with major UAE insurers including Daman (Thiqa and Enhanced), ADNIC, Nextcare, NAS and other networks. Because plans differ in coverage and pre-authorisation, our team verifies eligibility and secures approvals ahead of your visit. Self-pay options are available for those without applicable cover.

Areas We Serve

Al JimiAl TowiyyaAl MuwaijiAl MutaredhHiliAl SaroojAl KhabisiAl MaqamZakherAl Foah

Book a Clinical Consultation

Our Maternal Fetal Medicine specialists provide evidence-based assessment, clear counselling, and coordinated care.

Medical Content Reviewed by: Dr. Ali Al-Ibrahim (MFM Consultant)
Last updated: August 2026